Follow these steps to get results quickly.
The platform supports a broad range of genomic data types and research applications.
Full-genome analysis with comprehensive variant discovery across coding and non-coding regions. Ideal for population studies and rare variant research.
Ultra-deep coverage of protein-coding regions. Cost-efficient and highly precise for clinical and disease-focused research.
Maximum-depth analysis for curated target gene sets. Optimized for oncology, pharmacogenomics, and specialty clinical workflows.
BioSpark currently accepts paired-end sequencing files in standard compressed or uncompressed formats. Additional input formats are available for enterprise and custom workflows — contact our team for details.
The BioSpark engine delivers substantially faster turnaround compared to conventional pipelines. Targeted exome analyses are typically faster still.
Yes. All data is stored in isolated, encrypted environments with strict per-user access controls. We do not retain or share your data, and our infrastructure is designed to align with HIPAA and GDPR standards. Learn more on our Security page.
The standard pipeline uses the current human reference genome (GRCh38). Support for alternative reference builds and custom reference genomes is available for enterprise workflows.
BioSpark is currently in its POC (Proof of Concept) phase. You can apply for early access via the Pricing page. Our team will review your application and follow up with onboarding details.
Our team is happy to help with any technical or platform questions you have.